A rating of 90 puts Cara Therapeutics Inc (CARA) near the top of the Biotechnology industry according to InvestorsObserver. Cara Therapeutics Inc's score of 90 means it scores higher than 90% of stocks in the industry. Cara Therapeutics Inc also received an overall rating of 76, putting it above 76% of all stocks. Biotechnology is ranked 10 out of the 148 industries.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Cara Therapeutics Inc Stock Today?
Cara Therapeutics Inc (CARA) stock has fallen -2.29% while the S&P 500 is unmoved 0% as of 10:43 AM on Tuesday, Apr 28. CARA has fallen -$0.37 from the previous closing price of $16.17 on volume of 119,215 shares. Over the past year the S&P 500 has fallen -2.19% while CARA has fallen -18.85%. CARA lost -$2.49 per share the over the last 12 months.
